In a move that might make even Silicon Valley’s most seasoned disruptors do a double take, Palantir Technologies (PLTR) and Holtec International have announced a partnership that could reimagine the nuclear energy landscape. Their joint venture, called SMR-300, aims to supercharge the…
Eupraxia Pharmaceuticals , a clinical-stage biotechnology firm headquartered in Victoria, Canada, has quietly become one of the more intriguing stories on both sides of the border in 2025. The company’s shares now trade under the ticker EPRX on both the Nasdaq and…
What do you get when two mining titans decide to double down on one of the world’s richest iron ore regions? A $1.6 billion investment, a flurry of hard hats, and a renewed sense of optimism for Western Australia’s Pilbara, courtesy of…
In a move that both underlines scientific ingenuity and bolsters global health ambitions, GeoVax Labs, Inc. (GOVX) has announced the issuance of U.S. Patent No. 12,329,808, a milestone that covers a novel vaccine construct designed to prevent malaria infection. This patent, granted…
In the ever-evolving world of oncology, every so often a regulatory decision comes along that feels less like a footnote and more like a new chapter. The U.S. Food and Drug Administration’s (FDA) recent approval of Merck’s (MRK) Keytruda® (pembrolizumab) for resectable,…
Modular Medical, Inc. (NASDAQ: MODD) , a company with a knack for shaking up the insulin delivery market, is set to make a splash at the American Diabetes Association (ADA) 85th Scientific Sessions taking place June 20-23, 2025, at the McCormick…
In a world where vaccine innovation can sometimes feel like a slow-motion sprint, GeoVax Labs, Inc. (NASDAQ: GOVX) has just received a welcome boost—this time, courtesy of European regulators. The company, known for its nimble approach to tackling some of the world’s…
In the bustling digital amphitheater of Tribe Public’s latest CEO Presentation, the question of the hour was as sharp as it was timely: “Is the beaten down biotech sector the smartest bet in today’s volatile market?” With a flourish of slides and…
Once upon a time in east London, a boy with a mop of hair and a penchant for bending footballs around hapless defenders dreamed of wearing the red of Manchester United and the white of England. That boy, David Beckham, would one…
A Comeback Worth Cheering
After a long stretch that could best be described as a financial siesta, the U.S. IPO market is finally stretching its legs and putting on a show. As of June 11, 2025, U.S. IPOs have raised a…
